ZANCONATI, FABRIZIO
 Distribuzione geografica
Continente #
EU - Europa 41.333
NA - Nord America 23.952
AS - Asia 6.988
SA - Sud America 723
AF - Africa 149
Continente sconosciuto - Info sul continente non disponibili 62
OC - Oceania 36
Totale 73.243
Nazione #
IT - Italia 26.423
US - Stati Uniti d'America 23.761
PL - Polonia 4.989
SG - Singapore 2.543
SE - Svezia 2.252
CN - Cina 1.869
UA - Ucraina 1.566
HK - Hong Kong 1.466
DE - Germania 1.284
FR - Francia 883
RU - Federazione Russa 703
FI - Finlandia 630
BR - Brasile 625
GB - Regno Unito 494
NL - Olanda 463
TR - Turchia 435
IE - Irlanda 374
BG - Bulgaria 373
CH - Svizzera 221
BE - Belgio 165
IN - India 141
CA - Canada 139
VN - Vietnam 113
AT - Austria 85
ES - Italia 77
JP - Giappone 71
KR - Corea 69
EU - Europa 61
RO - Romania 61
SN - Senegal 47
CZ - Repubblica Ceca 41
IR - Iran 41
MX - Messico 31
AL - Albania 30
PT - Portogallo 30
AU - Australia 29
GR - Grecia 24
DK - Danimarca 23
HR - Croazia 23
AR - Argentina 22
MA - Marocco 22
SI - Slovenia 22
MY - Malesia 20
BD - Bangladesh 18
IQ - Iraq 17
EC - Ecuador 16
ID - Indonesia 16
SA - Arabia Saudita 16
CL - Cile 15
DZ - Algeria 15
IL - Israele 15
TW - Taiwan 15
ZA - Sudafrica 15
AE - Emirati Arabi Uniti 14
PK - Pakistan 14
RS - Serbia 14
EE - Estonia 13
LT - Lituania 11
NO - Norvegia 11
TH - Thailandia 11
AZ - Azerbaigian 10
CO - Colombia 10
EG - Egitto 10
LU - Lussemburgo 10
PY - Paraguay 10
GE - Georgia 9
KE - Kenya 9
PA - Panama 9
BO - Bolivia 8
UZ - Uzbekistan 8
KW - Kuwait 7
NZ - Nuova Zelanda 7
TN - Tunisia 7
VE - Venezuela 7
BY - Bielorussia 6
CI - Costa d'Avorio 6
LV - Lettonia 6
PE - Perù 6
SK - Slovacchia (Repubblica Slovacca) 6
SM - San Marino 6
AM - Armenia 5
JO - Giordania 5
PH - Filippine 5
HU - Ungheria 4
KG - Kirghizistan 4
KZ - Kazakistan 4
LK - Sri Lanka 4
MD - Moldavia 4
MO - Macao, regione amministrativa speciale della Cina 4
UY - Uruguay 4
LA - Repubblica Popolare Democratica del Laos 3
LB - Libano 3
NP - Nepal 3
OM - Oman 3
BB - Barbados 2
BF - Burkina Faso 2
CU - Cuba 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GA - Gabon 2
Totale 73.211
Città #
Warsaw 4.896
Woodbridge 2.489
Ann Arbor 2.223
Fairfield 2.146
Chandler 2.097
Houston 1.818
Trieste 1.570
Singapore 1.567
Ashburn 1.495
Jacksonville 1.424
Hong Kong 1.389
Milan 1.311
Rome 1.260
Wilmington 1.193
Seattle 818
Cambridge 722
Princeton 633
Boardman 605
Duino-Aurisina 536
Beijing 469
Columbus 390
Santa Clara 377
Sofia 369
Dublin 360
Naples 358
Izmir 326
Turin 304
Moscow 287
Florence 279
Dearborn 274
Bologna 245
Hefei 237
Padova 231
Palermo 189
Venezia 174
Frankfurt am Main 160
Düsseldorf 154
Napoli 153
Brussels 137
Munich 136
San Diego 135
Torino 131
Udine 129
Bari 127
Genoa 127
Catania 117
Dallas 117
Falls Church 117
Brescia 112
Helsinki 109
Verona 104
Redwood City 100
The Dalles 98
Dong Ket 95
Jinan 93
Bremen 89
Cagliari 86
Toronto 84
Perugia 79
Los Angeles 78
Shanghai 71
Treviso 71
Mestre 70
Chicago 68
Guangzhou 68
Nanjing 66
São Paulo 64
Venice 64
Redmond 62
North Bergen 61
Pisa 60
Bergamo 59
Des Moines 58
Nuremberg 57
Turku 57
Monza 55
Pescara 55
Phoenix 55
Caserta 54
Central District 54
Genova 54
Seoul 53
Norwalk 52
Vienna 52
Kocaeli 48
Mountain View 48
Como 47
Dakar 47
London 46
Messina 46
Grafing 45
Bern 44
Buffalo 44
Reggio Calabria 42
Vicenza 42
Ferrara 41
Kunming 41
Shenyang 39
Washington 38
Modena 37
Totale 40.063
Nome #
Valutazione quantitativa di Ki-67 nel carcinoma mammario: comparazione tra lettura al microscopio ottico e lettura con analizzatore automatico 21.438
VALUTAZIONE DEL TOUCH-IMPRINT CITOLOGICO NEL TRATTAMENTO DEL CANCRO DELLA MAMMELLA 1.232
Gestione delle pazienti con tumore fillode della mammella: esperienza triestina nel periodo 2006-2014 531
Il Registro Regionale delle Morti Cardiache Improvvise in età giovanile del Friuli Venezia Giulia. Protocolli operativi e risultati di un progetto multidisciplinare 525
An application of time-driven activity-based costing in a hospital setting 523
HUMAN PAPILLOMAVIRUS GENOTYPING IN OROPHARYNGEAL SQUAMOUS CELL CARCINOMA WITHOUT DNA EXTRACTION THROUGH EASYPAP DIRECT HPV DNA TEST 496
Polymer-mediated delivery of siRNAs to hepatocellular carcinoma: Variables affecting specificity and effectiveness 406
Cutaneous melanoma frequencies and seasonal trend in 20 years of observation of a population characterised by excessive sun exposure 397
Cyclin dependent kinase 4 and 6 inhibitors as novel therapeutic agents for targeted treatment of malignant mesothelioma 392
Potential applications of nanocellulose-containing materials in the biomedical field 390
Studio pilota sul ruolo dell’allattamento e dei fattori riproduttivi nel rischio dei carcinomi mammari Luminali nelle donne in premenopausa 386
Analisi dei tempi d’attesa tra le varie fasi di gestione dei carcinomi mammari screening-detected a Trieste nel biennio 2013-2014: come si può migliorare? 384
A simplified edge illumination set-up for quantitative phase contrast mammography with synchrotron radiation at clinical doses 379
Surgical and pathological changes after radiofrequency ablation of thyroid nodules 371
A vivens ex vivo study on the synergistic effect of electrolysis and freezing on the cell nucleus 368
Her2 immunohistochemical evaluation by traditional microscopy and by digital analysis, and the consequences for FISH testing 361
Evaluation of region selective bilirubin-induced brain damage as a basis for a pharmacological treatment 358
Fibrosi retroperitoneale e mesenterica. Una "sindrome da carcinoide" di non frequente riscontro 354
GT75 aptamer against eukaryotic elongation factor 1A as potential anticancer drug for castrate-resistant prostate cancer (CRPC). 347
Advances in systemic therapy for metastatic breast cancer: future perspectives 347
Breastfeeding: a reproductive factor able to reduce the risk of luminal B breast cancer in premenopausal White women 345
Association between benign thyroid disease and breast cancer: A single center experience 338
Cell-free DNA integrity for the monitoring of breast cancer: Future perspectives? 332
NEODUCTGENESIS AS A PROGNOSTIC MARKER IN “DUCTAL” CARCINOMA IN SITU OF THE BREAST 327
Complement Protein C1q binds to Hyaluronic Acid in the Malignant Pleural Mesothelioma Microenvironment and Promotes Tumour Growth 313
null 302
null 297
Usefulness of core needle biopsy for the diagnosis of thyroid Burkitt's lymphoma: a case report and review of the literature 295
Tumor-infiltrating lymphocytes and breast cancer: Beyond the prognostic and predictive utility 295
Histone acetylation as a new mechanism for bilirubin-induced encephalopathy in the Gunn rat 293
Need for randomized clinical trials testing targeted therapies in malignant pleural mesothelioma 280
Current status of PI3K-mTOR inhibition in hormone-receptor positive, HER2-negative breast cancer 276
Multicenter research into the quality of life of patients with advanced oropharyngeal carcinoma with long-term survival associated with human papilloma virus 273
Patient satisfaction after thyroid RFA versus surgery for benign thyroid nodules: a telephone survey 273
Pathological significance and prognostic value of surfactant protein D in cancer 264
Breast FNAC in Mammografic Screening Program of Trieste,Italy 262
An analysis of advanced cost accounting techniques in healthcare activities 257
X-ray phase-contrast tomography of breast tissue specimen with a multi-aperture analyser synchrotron set-up 255
Breast cytology: reporting 253
Tumour infiltrating lymphocytes and immune-related genes as predictors of outcome in pancreatic adenocarcinoma 253
Therapeutic potential of Nucleic acid-based drugs in coronary hyper-proliferative vascular diseases 245
Strategies for delivery of siRNAs to ovarian cancer cells 245
Parità e Allattamento quali fattori protettivi di carcinoma mammario nelle donne triestine 245
Breastfeeding is an additional protective factor for breast cancer among women living in the metropolitan area of Trieste. 241
Cyto-radiological disageement: management 241
Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion 240
Cell-free DNA analysis in healthy individuals by next-generation sequencing: a proof of concept and technical validation study. 236
Elevated levels of eEF1A2 protein expression in triple negative breast cancer relate with poor prognosis 235
RELIABILITY OF P16 IMMUNOHISTOCHEMISTRY IN THE DISCRIMINATION OF HPV-POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA 234
Fibromatosi mesenterica: descrizione di un caso ad esordio occlusivo intestinale 233
Is the Complement Protein C1q a Pro- or Anti-tumorigenic Factor? Bioinformatics analysis involving human carcinomas 230
Quantitative characterization of breast tissues with dedicated CT imaging 229
Deciduosi linfonodale ed ovarica versus metastasi di adenocarcinoma endocervicale in donna in gravidanza 227
Tumour infiltrating lymphocytes and PD-L1 expression as potential predictors of outcome in patients with malignant pleural mesothelioma 226
Interval Breast Cancer Versus Screen-Detected Cancer: Comparison of Clinicopathologic Characteristics in a Single-Center Analysis 225
Advancements towards the implementation of clinical phase-contrast breast computed tomography at Elettra 225
Monochromatic breast CT: absorption and phase-retrieved images 223
Radiofrequency ablation for benign thyroid nodules 216
Effect of class IV laser therapy on chemotherapy-induced oral mucositis: a clinical and experimental study. 215
Effects of formalin, methacarn, and fineFIX fixatives on RNA preservation. 212
Breast Cytopathology. Assessing the Value of FNAC in the Diagnosis of Breast Lesions 210
Monochromatic breast computed tomography with synchrotron radiation: phase-contrast and phase-retrieved image comparison and full-volume reconstruction 210
Management of the axilla in breast cancer: outcome analysis in a series of ductal versus lobular invasive cancers 207
The risk of developing a CIN2+ lesion in women with HPV16 and 18, versus women with other HPV types: follow up study 206
12-month efficacy of a single radiofrequency ablation on autonomously functioning thyroid nodules 205
Clinical mammography at the SYRMEP beam line 204
Prognostic-predictive factors in breast cancer: comparison of mRNA level (Target Print) and immunohistochemistry expression 203
Novel Lipid and Polymeric Materials as Delivery Systems for Nucleic Acid Based Drugs 202
Towards breast tomography with synchrotron radiation at Elettra: first images 200
Advances in systemic therapy for malignant mesothelioma: Future perspectives 199
Optimization of propagation-based x-ray phase-contrast tomography for breast cancer imaging 196
Breast tomography with synchrotron radiation 192
Translation Elongation 192
BIOINFORMATICS ANALYSIS OF THE CLINICOPATHOLOGICAL SIGNIFICANCE AND THE PROGNOSTIC ROLE OF SURFACTANT PROTEIN D IN LUNG, GASTRIC, BREAST AND OVARIAN CANCERS 192
Analisi delle caratteristiche dei carcinomi d’intervallo e screening detected a 10 anni dall’attivazione del programma di screening mammografico regionale del Friuli Venezia-Giulia nella provincia di Trieste 191
PROGNOSTIC ROLE OF TUMOR INFILTRATING LYMPHOCITES (TILS) IN EPITHELIOID PLEURAL MESOTHELIOMA 190
Biology, prognosis and response to therapy of breast carcinomas according to HER2 score 189
Characterization and significance of ACE2 and Mas receptor in human colon adenocarcinoma. 188
Un caso di linfoma primitivo della mammella: approccio diagnostico, problematiche di diagnostica differenziale e relative implicazioni terapeutiche 187
Charcoal suspension tattoo: new tool for the localization of malignant laterocervical lymph nodes 186
NOVEL BIOMARKERS FOR THE DIAGNOSIS OF LIVER FIBROSIS IN A HIGHLY RISK NAFLD COHORT in IFSO 2017 22(nd) World Congress 186
Dissecting the role of the elongation factor 1A isoforms in hepatocellular carcinoma cells by liposome-mediated delivery of siRNAs 185
The prognostic value of PI3K mutational status in breast cancer: A meta-analysis 185
Proposta di una checklist per la redazione del referto strutturato oncologico di anatomia ed istologia patologica ai fini del miglioramento della comprensione della diagnosi e dell’utilizzo della tecnologia sanitaria. 184
Toward Improving Breast Cancer Imaging: Radiological Assessment of Propagation-Based Phase-Contrast CT Technology 184
Measurement of the linear attenuation coefficients of breast tissues by synchrotron radiation computed tomography 184
Phase-contrast clinical breast CT: Optimization of imaging setups and reconstruction workflows 183
Survivin as a marker of cervical intraepithelial neoplasia and high-risk human papillomavirus and a predictor of virus clearance and prognosis in cervical cancer 182
SYRMEP: SR digital imaging of breast tissue samples 181
Metastatic angioimmunoblastic T-cell lymphoma started from thoracic paravertebral region: a Case report 181
MALIGNANT PLEURAL MESOTHELIOMA WITH “SIGNETRING” CELLS: A DIAGNOSTIC CHALLENGE AND AN UNUSUAL CASE REPORT 181
BREAST CYTOLOGY: AN EXAMPLE OF STRONG SYNERGY BETWEEN MORFOLOGY AND CLINICAL NEEDS 179
Liver and adipose tissue interplay through the up-regulation of the Th17 pathway 179
Caratteristiche dei carcinomi screening-detected a 6 anni dall’ avvio del programma di screening mammografico a Trieste 175
Aptamer targeting of the elongation factor 1A impairs hepatocarcinoma cells viability and potentiates bortezomib and idarubicin effects 175
High-resolution X-ray phase-contrast 3-d imaging of breast tissue specimens as a possible adjunct to histopathology 175
The PICASSO digital detector for Diffraction Enhanced Imaging at ELETTRA 174
Sentinel node in colon cancer: a multimodal approach 171
Breast citology 171
A simple in silico strategy identifies candidate biomarkers for the diagnosis of liver fibrosis in morbidly obese subjects 169
Totale 47.924
Categoria #
all - tutte 167.801
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 167.801


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020551 0 0 0 0 0 0 0 0 0 0 0 551
2020/20218.638 824 679 802 1.004 785 819 631 635 616 833 389 621
2021/20225.828 306 436 440 613 253 409 312 319 651 565 384 1.140
2022/202310.208 787 1.039 834 1.164 835 1.349 401 973 1.065 409 698 654
2023/20247.909 672 622 608 530 639 603 942 1.026 176 983 593 515
2024/202510.984 453 730 1.257 887 975 983 754 591 1.337 1.228 894 895
Totale 74.767